Attached files

file filename
8-K - FORM 8-K - Nutrastar International Inc.form8k.htm

Nutrastar Announces Full Year 2013 Results

Revenue Up 17.9% Year-Over-Year; Gross Margin at 77.8%

Harbin, China, March 26, 2014-- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris (“Cordyceps”), functional health beverages and organic and specialty foods, today announced its results for the year ended December 31, 2013.

Financial Highlights

  • Net revenue was $43.35 million, an increase of 17.9% from full year 2012.
  • Gross profit was $33.72 million, an increase of 20.4% from previous year, representing a gross margin of 77.8%.
  • Net income was $22.17 million, an increase of $4.93 million from year 2012, representing a net margin of 51.1%.
  • Basic and diluted EPS were $1.38 and $1.30, respectively, with 15.95 million basic shares and 17.09 million diluted shares outstanding.

Management Commentary

“We are pleased to report augmented sales in each of our consumer product categories for the full year 2013. Cordyceps product sales were up $5.94 million or 21.4% year-over-year. Functional health beverages containing Cordyceps and organic specialty foods, our ancillary consumer product categories, saw an 8.2% and 3.6% sales increase, respectively. As a whole, revenue was $43.35 million, up 17.9%, just short of our forecasted revenue of between $44 and $46 million due to a push out of the anticipated ramp up of our organic and specialty food business. As seen in past years, growing demand within China for our core consumer product Cordyceps was the primary driver of our overall increase in revenue.

As for our bottom line, we continue to operate at highly efficient and profitable levels, and see improvements in cost and operations. For the year ended December 31, 2013, gross profit and net income, as a percentage of revenue, increased to 77.8% and 51.1%, from 76.2% and 46.9%, respectively. Aiding in this improvement was the Q1 2013 completion of our multi-phase, multi-year production capacity expansion project. For the year 2013, we were at approximately 91 tons capacity and expect to hit the upper 90’s by the end of 2014,” Ms. Lianyun Han, CEO of Nutrastar, commented.

Ms. Han continued, “Right now, while we are in an excellent position to capitalize on numerous opportunities with the Chinese consumer product market, our focus remains steadfast on growing our core consumer product offerings. As the largest producer of commercially cultivated Cordyceps Militaris, we are keenly aware of market demand and are confident in our ability to stay on top of the competition particularly within China. As mentioned in our third quarter 2013 results, we are actively working towards expanding into the international market with our in-development Cordyceps capsules and tablets, designed to complement our current premium consumer product offering and cater to our everyday customer looking for an on-the-go health supplement similar to other vitamin-type supplements. This is a huge milestone we expect to achieve in 2015.”


On the subject of the Company’s financial position and growth ahead, Ms. Han added, “We closed the year with a cash balance of approximately $102.6 million. This cash balance was vouched and verified by our independent auditor, and is earmarked the Company’s future organic and inorganic growth initiatives such as continued capacity expansion, brand and product development, marketing & advertising, any potential strategic and synergistic acquisitions. With the proper, intelligent allocation of funds, we will continue building greater market awareness for our premium Cordyceps consumer products in China and ease our way into the international market with Cordyceps in tablet and capsule form.”

Nutrastar encourages any interested party to reach out to directly for more information on the Company and its innovative, premium consumer product portfolio.

Outlook for the Year Ending December 31, 2014

Based on management’s current expectations, full year 2014 revenue should fall in the range of $47 million to $50 million, representing an approximate 8% to 15% top line increase year-over-year.

Request for Call with Management

Investors are invited to request a call with Nutrastar’s management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

For more information regarding Nutrastar’s financial performance during the year ended December 31, 2013, please refer to the Annual Report on Form 10-K to be filed with the Securities and Exchange Commission on or about March 26, 2014.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com


Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

Safe Harbor Statement

This news release contains “forward-looking statements” relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Howard Gostfrand
American Capital Ventures
Tel: +1-305-918-7000
Email: info@amcapventures.com


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(AMOUNTS EXPRESSED IN US DOLLARS)

    Year Ended December 31,  
    2013     2012  
             

REVENUE

$  43,348,989   $  36,771,176  

 

           

Cost of goods sold

  (9,633,349 )   (8,742,166 )

 

           

GROSS PROFIT

  33,715,640     28,029,010  

 

           

Operating expenses:

           

 Selling expenses

  (1,848,488 )   (1,658,956 )

 General and administrative expenses

  (3,216,459 )   (3,102,070 )

Gain on re-measurement of accrued staff fringe and social benefits

  934,855     -  

 

           

Income from operations

  29,585,548     23,267,984  

 

           

Other income:

           

   Interest income

  324,145     255,918  

   Foreign exchange differences

  64,653     5,610  

   Change in fair value of warrants

  173     144,238  

   Other income

  8,073     7,921  

   Total other income

  397,044     413,687  

 

           

Income before income taxes

  29,982,592     23,681,671  

 

           

Provision for income taxes

  (7,812,222 )   (6,438,960 )

 

           

NET INCOME

$ 22,170,370   $ 17,242,711  

 

           

Earnings per share

           

   Basic

$  1.38   $  1.10  

   Diluted

$  1.30   $  1.04  

 

           

Weighted average number of shares outstanding

           

   Basic

  15,949,537     15,453,656  

   Diluted

  17,089,460     16,600,053  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  December 31,  

 

  2013     2012  

ASSETS  

 

CURRENT ASSETS

           

 Cash and cash equivalents

$  102,599,186   $  75,526,533  

 Accounts receivable

  56,922     81,497  

 Inventories

  691,847     965,251  

 Prepayments and other receivables

  1,300,012     1,321,726  

   Total current assets

  104,647,967     77,895,007  

OTHER ASSETS

           

 Intangible assets, net

  1,107,737     1,552,022  

 Property, plant and equipment, net

  15,481,249     15,991,060  

 

           

   Total assets

$  121,236,953   $  95,438,089  

LIABILITIES AND STOCKHOLDERS' EQUITY 

 

CURRENT LIABILITIES

           

 Other payables and accruals

$  1,167,957   $  1,481,198  

 Taxes payable

  2,879,172     2,981,136  

 Due to a related party

  265,223     150,036  

 Preferred stock dividend payable

  738,903     528,528  

 Warrants liabilities

  -     173  

   Total current liabilities

  5,051,255     5,141,071  

   Total liabilities

  5,051,255     5,141,071  

COMMITMENTS AND CONTINGENCIES

           

STOCKHOLDERS' EQUITY

           

 Preferred Stock, $0.001 par value, 1,000,000 shares authorized,
110,066 shares and 113,010 shares issued and outstanding, respectively;
aggregate liquidation preference amount: $3,081,848 and $3,164,280,
plus accrued but unpaid dividend of $738,903 and $528,528,
at December 31, 2013 and 2012, respectively

    2,510,183     2,577,324   

 

           

 Common stock, $0.001 par value, 190,000,000 shares authorized, 
16,421,161 shares issued and 16,377,606 shared outstanding at
December 31,2013; 15,907,381 shares issued and 15,863,826 shares
outstanding at December 31, 2012

    16,422       15,908  

     

           

 Additional paid-in capital

  19,934,551     19,029,586  

 Statutory reserves

  4,983,935     4,960,023  

 Treasury stock, at cost, 43,555 shares as of December 31, 2013 and 2012

  (78,767 )   (78,767 )

 Retained earnings

  80,242,877     58,325,932  

 Accumulated other comprehensive income

  8,576,497     5,467,012  

   Total stockholders' equity

  116,185,698     90,297,018  

 

           

   Total liabilities and stockholders' equity

$  121,236,953   $  95,438,089  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(AMOUNTS EXPRESSED IN US DOLLARS)

    Year Ended December 31,  
    2013     2012  

CASH FLOWS FROM OPERATING ACTIVITIES:

           

Net income

$  22,170,370   $  17,242,711  

Adjustments to reconcile net income to cash provided by operating activities:

           

   Change in fair value of warrants

  (173 )   (144,238 )

   IR warrant and restricted stock expense

  17,804     45,000  

   Depreciation and amortization

  1,473,496     1,235,468  

   Loss on disposal of property and equipment

  -     76,219  

   Share-based compensation expense

  801,396     809,664  

(Increase) decrease in assets:

           

             Accounts receivable

  26,676     1,216  

             Inventories

  298,548     (63,903 )

             Prepayments and other receivables

  61,626     (123,802 )

Increase (decrease) in liabilities:

           

             Accounts payable

  -     (6,327 )

             Other payables and accruals

  (351,591 )   412,785  

             Taxes payable

  (191,162 )   387,399  

         Net cash provided by operating activities

  24,306,990     19,872,192  

 

           

CASH FLOWS FROM INVESTING ACTIVITIES:

           

Purchase of property, plant and equipment

  -     (315,257 )

Refund of payments for building construction

  -     1,267,327  

         Net cash provided by investing activities

  -     952,070  

 

           

CASH FLOWS FROM FINANCING ACTIVITIES:

           

Purchase of common stock

  -     (69,214 )

Decrease in restricted cash

  -     4,170  

Advance from a related party

  46,173     64,829  

         Net cash provided by (used in) financing activities

  46,173     (215 )

 

           

Foreign currency translation adjustment

  2,719,490     146,157  

 

           

INCREASE IN CASH AND CASH EQUIVALENTS

  27,072,653     20,970,204  

CASH AND CASH EQUIVALENTS, at the beginning of the year

  75,526,533     54,556,329  

 

           

CASH AND CASH EQUIVALENTS, at the end of the year

$  102,599,186   $  75,526,533  

 

           

NON-CASH TRANSACTIONS

           

Preferred stock and dividend converted into common stock

$  86,279   $  995,587  

Preferred stock dividend payable

  229,513     200,382  

Share-based payment to officers and directors under equity incentive plan

  801,396     809,664  

Share-based payment – IR warrants and restricted shares

  17,804     45,000  

SUPPLEMENTAL DISCLOSURE INFORMATION

           

Income taxes paid

$  7,683,689   $   6,179,713